Media

Medical Devices

Australia digital health market to grow at 8% CAGR through 2034, forecasts GlobalData.

The digital health market in Australia is set for expansion. This growth reflects the increasing integration of digital technologies into healthcare and rising demand for more accessible, efficient, and personalized medical services. With these factors in play, the digital health market in Australia is set to grow at compound annual growth rate (CAGR) of approximately […]

Business Fundamentals

Cautious investor sentiment pulls global deal activity down 5% YoY in first four months of 2025, finds GlobalData

Cautious investor sentiment has weighed heavily on the global deal landscape, with mergers and acquisitions, private equity, and venture financing activities collectively declining by approximately 5% year-on-year (YoY) during the first four months of 2025. Geopolitical uncertainty and macroeconomic headwinds have prompted dealmakers to adopt a more selective, risk-averse approach, leading to a slowdown across […]

Pharma

Real-world data backs anti-IL-5 use in COPD with comorbid asthma, says GlobalData

Anti–IL-5 biologics, such as mepolizumab and benralizumab, have demonstrated significant efficacy in reducing moderate and severe exacerbations in patients with both asthma and chronic obstructive pulmonary disease (COPD), according to new real-world data presented at the 2025 American Thoracic Society (ATS) International Conference. These findings reinforce the therapeutic potential of eosinophil-targeting agents in patients with […]

Banking

Revolut’s EUR1 billion investment in France raises concerns over UK FinTech competitiveness, says GlobalData

Following the news that London-based FinTech giant Revolut Ltd plans to invest EUR1 billion in France and relocate its Western European headquarters to Paris; Harry Swain, Banking and Payments Analyst at GlobalData, a leading data and analytics company, offers his view: “Revolut’s shift towards a dual-headquarter model in Paris and Vilnius speaks volumes about the […]

Strategic Intelligence

Supply chain remains resilient in M&A landscape despite 13% YoY fall in deal value in Q1 2025, reveals GlobalData

Amid the impact of heightened geopolitical uncertainties and low growth across all the major economies, the first quarter of 2025 saw an overall decline in mergers and acquisitions (M&A) deal value of 13% compared to the same quarter in 2024. Supply chain resilience was the single most important theme, with $84 billion in supply chain-related […]

Insurance

US health insurance uptake faces uncertainty amid Trump’s policies, says GlobalData

Fewer than half of low-income individuals in the US have private health insurance*. Trump’s politics bring uncertainties to the pharmaceutical industry, which will likely translate into higher health insurance rates for consumers, potentially pricing out Americans with lower disposable income, while leaving others underinsured, according to GlobalData, a leading data and analytics company. According to […]

Sport

2025 Masters Tournament generates estimated sponsorship revenue of $60.45 million, reveals GlobalData

The 2025 Masters Tournament featured seven sponsors, with the Bank of America serving as the sole new sponsor for the year’s edition, distinguishing it from the previous year’s roster of sponsors. The Bank of America has agreed to serve as the Champion partner of the Masters’ Tournament. The partnership, which has been confirmed for the […]

Pharma

GSK’s Nucala highlights IL-5 inhibition in reducing COPD exacerbations in eosinophilic patients, says GlobalData

GSK’s Nucala (mepolizumab) demonstrated a consistent reduction in exacerbation rates among patients with eosinophilic chronic obstructive pulmonary disease (COPD), irrespective of prior severe event history, according to findings presented at the 2025 American Thoracic Society (ATS) International Conference. These results further solidify the role of IL-5 inhibition in biomarker-driven COPD management, says GlobalData, a leading […]

Pharma

Tezepelumab’s trial results strengthen potential for biomarker-driven biologic therapies in COPD, says GlobalData

Tezepelumab, a thymic stromal lymphopoietin (TSLP) inhibitor developed by AstraZeneca and Amgen, demonstrated significant reductions in chronic obstructive pulmonary disease (COPD) exacerbations among eosinophilic subgroups, regardless of chronic bronchitis status, according to new post hoc findings presented at the 2025 American Thoracic Society (ATS) International Conference. These results further support the potential for biomarker-driven biologic […]

Insurance

Malaysia general insurance industry to surpass $7 billion by 2029, forecasts GlobalData

The general insurance industry in Malaysia is projected to grow at a compound annual growth rate (CAGR) of 6.6% from MYR24.6 billion ($5.5 billion) in 2025 to MYR31.8 billion ($7.2 billion) by 2029, in terms of gross written premium (GWP), according to GlobalData, a leading data and analytics company. GlobalData’s Insurance Database estimates the Malaysian […]

Medical Devices

GlobalData highlights potential impact of US tariffs on medical tourism

US trade policy has seen notable changes recently, particularly with regard to import tariffs on countries such as China. Though these policies are usually justified by economic and geopolitical considerations, they also impact other areas, including the medical device industry and, more specifically, medical tourism. One growing outcome is how these tariffs are affecting medical […]

Business Fundamentals

Coinbase’s S&P 500 inclusion sparks optimism among influencers about cryptocurrency future, reveals GlobalData

Coinbase Global Inc. has garnered significant attention among social media influencers in the middle of May 2025, following the announcement of its upcoming inclusion in the S&P 500 index, marking the first instance of a cryptocurrency company being represented in this widely followed market benchmark. The shift from niche status to institutional recognition reflects a […]

Pharma

ICON retains lead as most active CRO in Q1 2025, reveals GlobalData

ICON maintains its place as the most active contract research organization (CRO) for Q1 2025 and Russia keeps its spot with the most clinical trials initiated in Europe despite the ongoing war with Ukraine, according to a report by GlobalData, a leading data and analytics company. GlobalData’s latest report “Q1 2025 Clinical Trials: CRO, Sponsor […]

Pharma

Record-breaking FDA biosimilar approvals to create opportunities for drug developers and manufacturers, says GlobalData

FDA biosimilar approvals reached a record 19 in 2024, with projections indicating that 2025 could surpass this milestone trend. This presents a golden opportunity for Contract Manufacturing Organizations (CMOs) specializing in biologics, as more blockbuster drugs approach patent expiration and regulatory barriers to entry diminish, says GlobalData, a leading data and analytics company. Kathryn Kinch, […]

Strategic Intelligence

Gene therapies drive growth of genomics market, says GlobalData

The integration of genomics into the pharmaceutical industry has allowed researchers to better understand the genetic factors underlying diseases, leading to the development of more targeted and effective therapies. Many of these therapies are designed to treat rare diseases that affect small patient populations. Generating $2.6 billion in sales in 2024, gene therapies are the […]

Oil & Gas

China to drive global ethylene capacity additions through 2030, says GlobalData

China is set to drive the global ethylene capacity additions, occupying a share of more than 36% by 2030, as both demand and supply of ethylene are expected to grow in the country, according to GlobalData, a leading data and analytics company. GlobalData’s latest report “Ethylene Market Analysis and Forecast by Products, Capacity Additions, Top […]

Business Fundamentals

Top EMEA banks see revenue surge in 2024 despite rate cuts and turmoil, finds GlobalData

The top 20 Europe, Middle East, and Africa (EMEA) banks saw a healthy 14% increase in combined revenue from $1.4 trillion in 2023 to $1.6 trillion in 2024, despite a challenging macroeconomic landscape defined by geopolitical friction, rate normalization, and tariff uncertainties, reveals GlobalData, a leading data and analytics company. Murthy Grandhi, Company Profiles Analyst […]

Oil & Gas

Tariff-related disruptions to outweigh other oil and gas themes, says GlobalData

US tariffs and energy security are expected to remain the focal points for oil and gas trade in 2025. Tariff-induced trade tensions might exert downward pressure on the US and global economy in the near term, potentially affecting the energy demand. It is therefore important for the industry to assess the impact of macroeconomic themes […]

Insurance

Hong Kong (China SAR) general insurance industry to reach $10.9 billion by 2029, forecasts GlobalData

The general insurance industry in Hong Kong (China SAR) is projected to grow at a compound annual growth rate (CAGR) of 5.1% from HKD69.9 billion ($8.9 billion) in 2025 to HKD85.4 billion ($10.9 billion) by 2029, in terms of gross written premium (GWP), according to GlobalData, a leading data and analytics company. According to GlobalData’s […]

Insurance

Insurers must resolve long-term problems to successfully sell to younger generations, says GlobalData

Insurers targeting younger generations face longstanding industry issues of a lack of understanding and a lack of consumer trust. While quicker fixes such as social media strategies and more flexible products may help somewhat, they would only appeal to a small proportion, so the more long-term issues need to be addressed to reach these generations, […]

Prev 1 … 76 77 78 79 80 … 785 Next

Australia digital health market to grow at 8% CAGR through 2034, forecasts GlobalData.

Cautious investor sentiment pulls global deal activity down 5% YoY in first four months of 2025, finds GlobalData

Real-world data backs anti-IL-5 use in COPD with comorbid asthma, says GlobalData

Revolut’s EUR1 billion investment in France raises concerns over UK FinTech competitiveness, says GlobalData

Supply chain remains resilient in M&A landscape despite 13% YoY fall in deal value in Q1 2025, reveals GlobalData

US health insurance uptake faces uncertainty amid Trump’s policies, says GlobalData

2025 Masters Tournament generates estimated sponsorship revenue of $60.45 million, reveals GlobalData

GSK’s Nucala highlights IL-5 inhibition in reducing COPD exacerbations in eosinophilic patients, says GlobalData

Tezepelumab’s trial results strengthen potential for biomarker-driven biologic therapies in COPD, says GlobalData

Malaysia general insurance industry to surpass $7 billion by 2029, forecasts GlobalData

GlobalData highlights potential impact of US tariffs on medical tourism

Coinbase’s S&P 500 inclusion sparks optimism among influencers about cryptocurrency future, reveals GlobalData

ICON retains lead as most active CRO in Q1 2025, reveals GlobalData

Record-breaking FDA biosimilar approvals to create opportunities for drug developers and manufacturers, says GlobalData

Gene therapies drive growth of genomics market, says GlobalData

China to drive global ethylene capacity additions through 2030, says GlobalData

Top EMEA banks see revenue surge in 2024 despite rate cuts and turmoil, finds GlobalData

Tariff-related disruptions to outweigh other oil and gas themes, says GlobalData

Hong Kong (China SAR) general insurance industry to reach $10.9 billion by 2029, forecasts GlobalData

Insurers must resolve long-term problems to successfully sell to younger generations, says GlobalData

Browse

Company information